文献速递慢性肾脏病

哺乳期肾脏保护药物的使用:证据、挑战与药代建模前景

Use of kidney-preserving medications in breastfeeding.
PubMed 文献 · Kidney Int · 2026-02-13

本文综述哺乳对CKD母亲及其子女的血管保护益处,指出CKD产后女性常需肾脏保护药物但缺乏哺乳安全数据,可能导致治疗不足。文章汇总现有药物哺乳安全数据,并介绍药代动力学建模等新兴方法以弥补人类数据缺口。

要点

  • 哺乳可降低母亲血压、改善血脂并降低2型糖尿病风险,对CKD母亲尤其重要。
  • 哺乳儿远期肥胖、高血压和糖尿病风险降低,血管健康获益明确。
  • CKD常用药物哺乳安全数据缺乏,产后女性可能被剥夺肾脏保护治疗。

核心结论

  • 哺乳对CKD母亲及其子女具有血管保护益处,但CKD治疗药物哺乳安全数据缺乏可能限制肾脏保护治疗的使用。

研究设计与样本

  • 综述,总结哺乳对CKD女性及其子女的重要性及CKD治疗药物在哺乳期的安全性数据。

主要发现

  • 哺乳与母亲血压降低、体重减轻、血脂改善及2型糖尿病预防相关。
  • 哺乳儿肥胖、高血压和糖尿病风险降低,远期血管健康改善。
  • 许多CKD治疗药物缺乏稳健的哺乳安全数据,产后CKD女性可能因此无法获得影响长期肾脏存活的肾脏保护治疗。

临床怎么用

  • 临床应重视哺乳对CKD母亲及子女的血管保护价值,并关注CKD治疗药物在哺乳期的安全性评估。
  • 对于人类数据稀少的药物,可借助药代动力学建模辅助哺乳安全决策。

局限性

  • 许多CKD治疗药物缺乏稳健的哺乳安全数据。
  • 在产后女性及其婴儿中开展研究存在伦理和实践障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breastfeeding has recognized health benefits for all mother-infant dyads, which are particularly important for women with chronic kidney disease (CKD) and their children. There is growing evidence to suggest breastfeeding positively impacts maternal vascular health by lowering blood pressure, assisting with weight loss, improving lipid profiles, and preventing type 2 diabetes. Similarly, breastfed infants have demonstrated decreased risks of developing obesity, hypertension, and diabetes, improving their long-term vascular health. Postpartum women with CKD often require different therapies to manage their disease and improve long-term outcomes, but there is a lack of robust lactation safety data for many drugs used in the treatment of CKD. As a result, postpartum women with CKD may be deprived of nephroprotective therapies that impact long-term renal survival or the vascular protective effects associated with breastfeeding for themselves and their children. In this review, we summarize the importance of breastfeeding for women with CKD and their children, and existing data on the safety of drugs used for the treatment of CKD in lactation. We also review available methods for assessing drug safety and describe emerging pharmacometric modeling techniques that may be particularly useful for informing safety in lactation for drugs with little human data, helping to overcome some of the ethical and practical issues associated with conducting research on postpartum women and their infants.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Parnizari P, Zipursky JS, Hladunewich MA, et al. Use of kidney-preserving medications in breastfeeding. Kidney Int. 2026. PMID: 41692344. doi:10.1016/j.kint.2025.12.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。